-
EHJ: The cardiovascular risk of "two kings" allopurinol and benzbromarone in gout patients
Time of Update: 2021-09-19
In summary, compared with benzbromarone, allopurinol is associated with an increased risk of compound CVD events and all-cause death.
In summary, compared with benzbromarone, allopurinol is associated with an increased risk of compound CVD events and all-cause death.
-
Nat Med: Cellular and humoral immune responses of patients with multiple sclerosis treated with anti-CD20 after being vaccinated with SARS-CoV-2 mRNA vaccine
Time of Update: 2021-09-19
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy .
https:// -021-01507-2Cellular and humoral immune responses following SARS- CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy in this message
-
BJD: Observation of the continuous efficacy of Skuchiyuumab in the treatment of moderate to severe palmoplantar psoriasis
Time of Update: 2021-09-19
5 years) safety and effectiveness of subcutaneous injection of Suckinumab 150 and 300 mg in 205 patients with moderate to severe palmoplantar psoriasis (PpPsO) .
5 years) safety and effectiveness of subcutaneous injection of Suckinumab 150 and 300 mg in 205 patients with moderate to severe palmoplantar psoriasis (PpPsO) .
-
BJD: Efficacy and safety of risacizumab vs. scocilizumab in patients with moderate to severe plaque psoriasis
Time of Update: 2021-09-19
Risankizumab and Suckinumab inhibit interleukin (IL)-23 and IL-17A, respectively, and are effective for adult patients with moderate to severe plaque psoriasis, but the dosage regimen is different .
-
Traditional Chinese medicine compound can effectively delay the progression of rheumatoid and improve the prognosis of patients
Time of Update: 2021-09-19
Rheumatoid arthritisRecently, Professor Huang Runyue's team from Guangdong Provincial Hospital of Traditional Chinese Medicine published a paper "Systematic Evaluation of the Effects of Chinese Herbal Compounds Treating Rheumatoid Arthritis on Rheumatoid Factor and Anti-cyclic Citrullinated Peptide Antibodies " in the internationally renowned journal "Frontiers in Pharmacology" (IF: 5.
-
Lancet Rheumatology: Tocilizumab monotherapy for giant cell arteritis after ultra-short glucocorticoid administration: a single-arm, open-label, proof-of-concept study
Time of Update: 2021-09-18
Trial recruited 50 over the age of new diagnostic giant cell arteritis ( screening prior to Visit 4 American College of Rheumatology criteria or big weeks) in line with the vessel vasculitis polymyalgia rheumatica patients .
-
What happens if a patient with rheumatism immunity gets a lipolysis injection?
Time of Update: 2021-09-12
Here, the case we are going to talk about today is a case of a patient with rheumatoid arthritis who suffered secondary mumps after injection of Kybella fat-dissolving needles on both sides of the maxillofacial region .
-
How to treat rigidity effectively?
Time of Update: 2021-09-12
Non-steroidal anti-inflammatory drugs, as the first choice for symptomatic treatment of patients with either early or late stages of rigidity, can quickly improve the patients' back pain and morning stiffness, reduce joint swelling and pain, and increase the range of motion .
-
What should I do if there is a lupus erythematosus crisis?
Time of Update: 2021-09-12
Usually need high-dose methylprednisolone shock therapy, symptomatic and supportive treatment for the affected organs .
Usually need high-dose methylprednisolone shock therapy, symptomatic and supportive treatment for the affected organs .
Usually need high-dose methylprednisolone shock therapy, symptomatic and supportive treatment for the affected organs .
-
Teach you how to identify the difference between urinary tract infection and lupus nephritis
Time of Update: 2021-09-12
It can be seen from this that it is precisely because patients with lupus erythematosus receive long-term hormone and immunosuppressive therapy that the body's immune function is low, which leads to a significant increase in the incidence of infection [3] .
-
JAHA: Corticosteroid and immunosuppressive therapy for cardiac sarcoidosis
Time of Update: 2021-09-11
Prevention of corticosteroids and/or immunosuppressive therapy in patients with cardiac sarcoidosis in both cases with atrioventricular nodal conduction and recovery of left ventricular function are associated with positive outcomes .
-
The effect of systemic lupus erythematosus on the kidneys
Time of Update: 2021-09-11
The currently widely used classification divides SLE-related glomerular diseases into 6 types based on the results of kidney biopsy.
The currently widely used classification divides SLE-related glomerular diseases into 6 types based on the results of kidney biopsy.
-
Repeated miscarriage?
Time of Update: 2021-09-11
What is recurrent miscarriage?Among pregnancy-related diseases, recurrent spontaneous abortion (RSA) is an important type of reproductive health problem .
Among pregnancy-related diseases, recurrent spontaneous abortion (RSA) is an important type of reproductive health problem .
-
Circulation: The effect of colchicine on acute myocardial injury
Time of Update: 2021-09-11
It can be seen that in this randomized, placebo-controlled trial, oral high-dose colchicine during reperfusion and 5 days did not reduce IS assessed by cardiac magnetic resonance imaging .
In this randomized, placebo-controlled trial, oral high-dose colchicine during reperfusion and 5 days did not reduce IS assessed by cardiac magnetic resonance imaging .
-
Traditional Chinese and Western medicine treatment of Hashimoto's thyroiditis
Time of Update: 2021-09-11
The action characteristics of TCM "taking peace for a period of time" can help restore immune homeostasis, and the use of integrated traditional Chinese and Western medicine treatments will be more conducive to controlling the progress of autoimmune diseases .
-
J Rheumatol: The safety of guseculumab in the treatment of psoriatic arthritis
Time of Update: 2021-09-11
This article uses two Phase III trials of 1-year data ( DISCOVER-1 and 2-DISCOVER ) , assessment of Gousse library monoclonal antibody therapy safety psoriatic arthritis (PsA) is .
-
J Rheumatol: Risk factors for psoriatic arthritis, psoriasis, rheumatoid arthritis, and ankylosing spondylitis
Time of Update: 2021-09-11
A recent study published in the authoritative journal of rheumatology J Rheumatol compared the potential risk factors of psoriatic arthritis (PsA), psoriasis, rheumatoid arthritis (RA) and ankylosing spondylitis (AS) .
-
JBMR: The effect of Odanacatib on bone structure and quality of postmenopausal women with osteoporosis
Time of Update: 2021-09-10
Regarding periosteal modeling, compared with placebo, the proportion of periosteal double-label patients and the bone formation index of ODN-treated patients increased over time .
Compared with placebo, the proportion of periosteal double-label patients and bone formation index in ODN-treated patients increased over time .
-
ARD: Analysis of the effect of Brodalumab in the treatment of psoriatic arthritis
Time of Update: 2021-09-10
Pedaluzumab 210 mg is currently approved for the treatment of moderate to severe plaque psoriasis in the United States, the European Union, Canada and certain Asian countries.
Moderate to severe plaque psoriasis in some Asian countries, currently only used for psoriatic arthritis (PsA) in JapanThe experiment randomly assigned 962 patients .
-
Semin Arthritis Rheu: The prognosis of rheumatoid arthritis patients infected with the new crown
Time of Update: 2021-09-10
The mortality rate of the RA cohort, hospitalization rate, ICU occupancy rate, mechanical ventilation, severe COVID-19, acute kidney injury, renal replacement therapy/hemodialysis, acute respiratory distress syndrome-ARDS, ischemic stroke, venous thromboembolism-VTE, and sepsis risk are higher than those of non-RA Patients with new crowns are higher than non-RA patients with new crowns.
